![]() Sunday, Sep 07, 2003 |
| Business | ||||
|
News:
Front Page |
National |
Southern States |
Other States |
International |
Opinion |
Business |
Sport |
Miscellaneous |
Advts: Classifieds | Employment | Obituary | Business
MUMBAI: The board of directors of Arvind Remedies has given an in principle sanction to the proposal of Citiconsult Emerging Markets of the U.K. for investing in the company up to an amount of Rs. 1 crore at Rs. 11 per equity share of one each and has recommended the management to proceed with discussions and deliberations. The board also approved the provisions enabling FII limit in the company to 24 per cent. Our Bureau
Printer friendly
page
News:
Front Page |
National |
Southern States |
Other States |
International |
Opinion |
Business |
Sport |
Miscellaneous |
|
|
|
The Hindu Group: Home | About Us | Copyright | Archives | Contacts | Subscription Group Sites: The Hindu | Business Line | The Sportstar | Frontline | The Hindu eBooks | Home |
Copyright © 2003, The
Hindu. Republication or redissemination of the contents of
this screen are expressly prohibited without the written consent of
The Hindu
|